课题基金 / 基金详情

Evaluating Insulin-like Growth Factor-Binding Protein 3 (IGFBP3) as a novel drug target in Head and Neck Cancer

Evaluating Insulin-like Growth Factor-Binding Protein 3 (IGFBP3) as a novel drug target in Head and Neck Cancer
评估胰岛素样生长因子结合蛋白 3 (IGFBP3) 作为头颈癌新药物靶点
批准号:
466615
负责人:
Fotiadou Iosifina
金额:
$1.27万
依托单位:
依托单位国家:
加拿大
项目类别:
Studentship Programs
财政年份:
2021
资助国家:
加拿大
项目状态:
已结题
起止时间:
2021-12-01 至 2022-12-01

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Head and Neck Squamous Cell Carcinoma (HNSCC) is one of the deadliest and most prevalent cancers with rising incidence. The treatment options are non-selective and associated with toxicities and other adverse effects, thus highlighting the need for novel
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金